Capricor Therapeutics, Inc.
HealthcareNASDAQ:CAPR · NASDAQ Global Select
+$0.76 today
Vol 0.77M · Avg 1.11M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+119.02%
Period High
$35.34
Period Low
$4.60
Latest
$25.80
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$566.68M
Cabaletta Bio, Inc.
NASDAQ:CABA
$490.79M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$463.35M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$353.00M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$343.14M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$250.78M
Editas Medicine, Inc.
NASDAQ:EDIT
$244.75M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$198.11M
ProQR Therapeutics N.V.
NASDAQ:PRQR
$151.72M
Immutep Limited
NASDAQ:IMMP
$53.60M
What is the latest CAPR filing?
The latest filing shown is 8-K dated Jun 8, 2026.
How many recent filings does CAPR have?
Intrinsic Alpha currently shows 20 recent filings for CAPR.
Explore More
Continue the stock analysis
Jump to another research area for this company.